ACN vs AKAM Stock Comparison
Scores Breakdown
| Metric | ACN | AKAM |
|---|---|---|
| 📈 Growth | 28/30 | 22/30 |
| 💰 Profitability | 16/20 | 17/20 |
| 🏦 Financial Health | 18/20 | 17/20 |
| 💵 Valuation | 15/20 | 16/20 |
| ⚠️ Risk (lower is better) | 5/10 | 4/10 |
| Overall Score | 82/100 | 78/100 |
Side-by-Side Summaries
| ACN Analysis | AKAM Analysis |
|---|---|
📈 Growth & Financial TrajectoryOver the eight quarters, Revenues rose from $17.69B to $18.72B, while Net Income increased from $1.79B to $2.34B, signaling a positive trajectory with modest top-line growth and stronger bottom-line advancement. The trend shows resilience amid quarterly fluctuations, with mid-single-digit revenue growth and improving profitability. 💰 Margins & Cash FlowGross Margin sits in the low 30s (about 32%–33%), and Operating Margin runs in the mid-teens, supporting the Net Income growth. Cash flow is robust: Net Cash Flow From Operating Activities around $3.0–3.8B per quarter; Net Cash Flow overall was positive in several periods, while Net Cash Flow From Investing Activities and Net Cash Flow From Financing Activities show volatility. 🛡️ Balance Sheet & LiquidityLiquidity remains solid with Current Assets around $25–29B versus Current Liabilities around $18–22B (current ratio near 1.3x). Equity sits near $31–33B, and overall liabilities are manageable relative to assets. ⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryOver the 8 quarters, AKAM's revenues rose from about $1.00B to about $1.10B, a modest expansion of ~9-10%, with a steady uptrend across quarters. Net income moved from roughly $58M in 2024-Q3 to a peak of about $140M in 2025-Q3, before printing around $79M in 2026-Q2, reflecting quarterly volatility but positive trajectory. 💰 Margins & Cash FlowGross margin stayed robust in the mid-to-high 50s% (Q2 2026 ~55.8%; Q4 2025 ~58.6%; Q3 2025 ~59.2%). Operating income remained positive in every quarter shown. Operating cash flow (continuing) was solid, e.g., around $326M in 2026-Q2. Net cash flow turned positive in 2026-Q2 at roughly $0.85B, with investing cash outflows offset by financing inflows in several quarters, indicating healthy cash generation despite capex. 🛡️ Balance Sheet & LiquidityAssets near $15.1B in 2026-Q2, liabilities around $10.3B, and equity about $4.75B. Current assets vs current liabilities yield a comfortable liquidity cushion (approx. 1.6x). Leverage remains moderate with substantial noncurrent assets and conservative equity backing. ⚠️ Key Drivers & Risks
|